Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

TriLink – CleanCap® M6 IVT Kit, High Yield

Streamline your mRNA synthesis with TriLink’s CleanCap® IVT kits, which yield up to 1 mg per 100 µL reaction. Designed for efficiency and excellence, these kits include all components to generate high-quality mRNA using in vitro transcription (IVT) with CleanCap® co-transcriptional capping.

CleanCap® M6 IVT Kit, High Yield

  • Includes Trilink’s newest cap analog, CleanCap® M6, for those aiming for even higher protein expression than with enzymatic caps and previous CleanCap® AG analogs
  • May require 5’-UTR sequence review for optimal yield
  CleanCap® AG (3′ OMe) CleanScript™ IVT Kit CleanCap® M6 IVT Kit, High Yield
Cap analog CleanCap® AG (3′ OMe) CleanCap® M6
Protein expression level Higher than the original CleanCap® AG analog Higher than enzymatic caps and previous CleanCap AG analogs
Construct to make mRNA with AG start mRNA with AG start
Considerations Versatile 5′ UTR sequence may affect yield
Included modified rNTP N1-methylpseudouridine N1-methylpseudouridine
Included 10X buffer CleanScript™ IVT Buffer M6 IVT Buffer
Included enzyme mix AG CleanScribe™
RNA Polymerase Mix
M6 CleanScribe™
RNA Polymerase Mix
Expected yield
(per 100 μL rxn)
0.8-1 mg 0.8-1 mg*

*Following its pulse-feed protocol


Learn more about TriLink High-Yield IVT kits with CleanCap® capping technology

Download the brochure >

 

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Request a Quote

Request Quote

Recent Posts

2027 Abacus dx Emerging Investigators Grant

COMING SOON Grant in Research Funding Empowering the Next Generation of Scientific Leaders Stay tuned for the 2027 Abacus dx Emerging Investigators Grant. More information…

Read full article

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article